
NanoViricides Highlights Broad-Spectrum Antiviral Candidate Following Andes Hantavirus Incident
NanoViricides points to its clinical-stage antiviral NV-387 as a potential broad-spectrum treatment for emerging viral threats after a recent Andes hantavirus outbreak on a cruise ship.
Read full story























